Global battery manufacturer Ultralife Corporation will launch its latest LiFePO4 lead acid replacement battery for the medical sector ahead of this year’s HIMSS healthcare and IT conference in Orlando, Florida. Visitors will be able to view the new product on Booth 2287 at the show, at the Orange County Convention Centre from February 19 to 23, 2017.
Ultralife will launch the new smart LiFePO4 battery in advance of this year’s HIMSS conference, giving the 45,000 visitors the opportunity to view the battery, which delivers higher performance than traditional sealed lead acid (SLA) batteries. As visitors to the conference will know, portable electronic devices are becoming much more vital to patient care. It is therefore vital that the new generation of batteries offer a high level of reliability for health professionals to use in medical devices.
Traditional SLA batteries are often used in medical carts, wheelchairs, scooters, robotics and motor bots or uninterrupted power supply (UPS) systems, which supply emergency power when the main power fails, yet Ultralife LiFePO4 batteries outperform them on nearly every measure.
The HIMSS conference allows medical professionals to see how IT can help in their day-to-day work. Many companies, including Ultralife, are exhibiting products, which use the latest technologies to improve the capability of devices in the medical sector. With over 300 training and discussion sessions on offer, the conference attracts a wide range of medical staff looking to improve their area of expertise.
“Although we can’t give too much away ahead of the big launch in the run up to HIMSS, this new LiFePO4 battery brings some key improvements over traditional SLA batteries. In addition, we’ve taken the decision to keep this product on home soil and assemble the battery in our NY plant so customers can be assured of exceptional quality and fast delivery times” explained Mike Manna, vice president of product management and technology at Ultralife Corporation.
“Medical professionals need batteries for increasingly demanding applications where high power, accurate monitoring and fast charging are becoming a necessity. Our range of LiFePO4 lead acid replacement batteries are guaranteed to not only deliver on this necessity, but are also three times lighter – significantly reducing the weight of their device or, if weight reduction isn’t a factor, providing three times more energy.”
Ultralife is an expert in batteries for mission critical devices in the medical and defence sectors. The company, based in Newark, New York state, manufactures a wide range of non-rechargeable and rechargeable cells, batteries and power systems across the world.
The launch of Ultralife’s new Lithium Iron Phosphate (LiFePO4) battery will be announced on Ultralife’s website before the HIMSS conference in Florida. To find out more about the product, visit Ultralife on Booth 2287 from February 19 to 23, 2017 or make a preliminary enquiry ahead of the launch here.